Trial Site Detail

 

Drug:
Imatinib
Trial:
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) (Novartis CSTI571BUS282)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Northeast Georgia Cancer Center (ACORN)

     
Athens , GA 30607
USA

 

Principal Investigator:
 Petros Nikolinakos, MD
Contact:
 Jamie Hodgson 706-353-2990 ext 279
Activation Status of this Site:
 Closed
Notes about this Site:
Northeast Georgia Cancer Center (ACORN) Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.